By the end of 2024, the total number of medical and health institutions nationwide reached 1,093,551, an increase of 22,766 compared to the previous year.

Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.

Find out what is going on in Chinese in vitro diagnostic industry.

Recently, Shanghai Runda Medical Technology Co., Ltd. disclosed to the public that the company will acquire part of the shares of two IVD companies in Anhui and Shanghai at a price of 328 million.

Till this report, there are 14 Chinese IVD enterprise successfully developed the B.1.1.7 testing kits.

The State Council Information Office P.R.C.announced that the Sinopharm COVID-19 Vaccine has been approved.

2020 has been a magical year for the in vitro diagnostic industry. How will history record the year 2020?

Find out what is going on in Chinese in vitro diagnostic industry.

Vazyme's IPO was Accepted, Planning to Raise 1.225 Billion Yuan; Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China.

Another Capital Raising Boom in in vitro diagnostic industry.

In recent years, because of the optimistic attitude about the development of IVD industry, various VC and PE investments are very active.

On December 19, at the 16th International Respiratory Symposium in Changshu, Abbott announced that it had joined the International Smart Health Alliance and signed an important strategic cooperation with the China Lung Cancer Prevention Alli